Cost-effectiveness of rosiglitazone monotherapy compared with glibenclamide monotherapy for treating Type 2 diabetes

被引：0
|
作者：
Beale, S [1 ]
Bagust, A [1 ]
Downs, KE [1 ]
Perry, AS [1 ]
机构：
[1] Univ York, York Hlth Econ Consortium, York YO1 5DD, N Yorkshire, England
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
932
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [21] Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis
    Chescheir, Nancy C.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (04): : 847 - 847
  • [22] Rosiglitazone monotherapy for type 2 diabetes mellitus -: too soon to ADOPT?: Commentary
    Gaede, Peter
    Pedersen, Oluf
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 456 - 457
  • [23] COST-EFFECTIVENESS OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN THE TREATMENT OF SEVERE ACTIVE RA
    Carlson, J. J.
    Ogale, S.
    Dejonckheere, F.
    Sullivan, S. D.
    VALUE IN HEALTH, 2012, 15 (07) : A447 - A447
  • [24] Cost-effectiveness in Germany of rosiglitazone-metformin combination in Type 2 diabetes.
    Bagust, A
    Shearer, A
    Schoeffski, O
    Reitberger, U
    Goertz, A
    Behrens, M
    DIABETOLOGIA, 2003, 46 : A444 - A444
  • [25] Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK
    Sophie Beale
    Adrian Bagust
    Arran T. Shearer
    Alan Martin
    Lisa Hulme
    PharmacoEconomics, 2006, 24 (Suppl 1) : 21 - 34
  • [26] COST-EFFECTIVENESS OF ROSIGLITAZONE COMBINATION THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES IN THE CZECH REPUBLIC
    Dolezal, T.
    Skoupa, J.
    Taylor, M. J.
    Whitehead, S.
    Rausova, V
    Pavlikova, P.
    VALUE IN HEALTH, 2008, 11 (06) : A504 - A504
  • [27] Cost-effectiveness of indapamide monotherapy in stroke prevention in Hungary
    Brodszky, V.
    Karpati, K.
    Majer, I.
    Nagy, V.
    Farsang, C.
    Gulacsi, L.
    JOURNAL OF HYPERTENSION, 2007, 25 : S222 - S222
  • [28] Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia
    Bekele, Mengistu
    Norheim, Ole Frithjof
    Hailu, Alemayehu
    MDM POLICY & PRACTICE, 2021, 6 (01)
  • [29] THE COST-EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY IN SPAIN
    Nielsen, A. T.
    Pitcher, A.
    Lovato, E.
    Schubert, A.
    Hemels, M.
    Neslusan, C.
    Gonzalez, B.
    VALUE IN HEALTH, 2015, 18 (03) : A61 - A61
  • [30] Cost-effectiveness of adding sitagliptin vs. an sulfonylurea in Swiss patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Brandle, M.
    Chen, J.
    Alemao, E.
    Yin, D.
    Cook, J.
    Szucs, T.
    DIABETOLOGIA, 2008, 51 : S446 - S446
12345